Methane production and colon cancer.

Area of Science:

• Gastroenterology and Oncology
• Microbiome Research
• Breath Analysis Diagnostics

Background:

• The link between methane production and colorectal cancer (CRC) incidence remains unclear.
• Methane-producing microorganisms are increasingly recognized for their role in gastrointestinal health and disease.
• Understanding gut microbiome alterations in CRC is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate the prevalence of methane production in patients with colorectal cancer.
• To compare methane production in CRC patients with healthy controls and patients with benign colon diseases.
• To assess the impact of tumor resection on methane production in CRC patients.

Main Methods:

• End-expiratory breath sampling technique used to measure methane production.
• Study included 270 individuals across eight groups: healthy controls, CRC patients (resectable and non-resectable tumors), and patients with various nonmalignant colon diseases.
• Statistical analysis (p-values) used to determine significant differences in methane production rates between groups.

Main Results:

• Significantly higher methane production (91.4%) observed in CRC patients compared to healthy controls (42.9%) and patients with benign colon diseases (41.3%).
• Following tumor resection, methane production in CRC patients decreased to 47.2%, similar to controls.
• Patients with non-resectable tumors maintained high methane production (87.7%). Increased methane production was also noted in extensive ulcerative colitis and colonic polyposis.

Conclusions:

• Colorectal cancer directly influences methane production in the large bowel.
• Tumor resection significantly reduces methane production, indicating a direct link between the malignancy and microbial activity.
• Conditions with a high risk of malignancy show a higher prevalence of methane producers, suggesting potential as a biomarker.